175 related articles for article (PubMed ID: 36424021)
21. Toll-like receptor-mediated inflammation markers are strongly induced in heart tissue in patients with cardiac disease under both ischemic and non-ischemic conditions.
Rotter Sopasakis V; Sandstedt J; Johansson M; Lundqvist A; Bergström G; Jeppsson A; Mattsson Hultén L
Int J Cardiol; 2019 Oct; 293():238-247. PubMed ID: 31230935
[TBL] [Abstract][Full Text] [Related]
22. Cardio-Rheumatology: Cardiovascular Complications in Systemic Autoimmune Rheumatic Diseases / Is Inflammation the Common Link and Target?
Manolis AS; Tzioufas AG
Curr Vasc Pharmacol; 2020; 18(5):425-430. PubMed ID: 32410564
[TBL] [Abstract][Full Text] [Related]
23. Antibodies to common infectious agents in coronary artery disease patients with and without rheumatic conditions.
Grub C; Brunborg C; Hasseltvedt V; Aukrust P; Førre O; Almdahl SM; Hollan I
Rheumatology (Oxford); 2012 Apr; 51(4):679-85. PubMed ID: 22157685
[TBL] [Abstract][Full Text] [Related]
24. Endothelial dysfunction in rheumatic autoimmune diseases.
Murdaca G; Colombo BM; Cagnati P; Gulli R; Spanò F; Puppo F
Atherosclerosis; 2012 Oct; 224(2):309-17. PubMed ID: 22673743
[TBL] [Abstract][Full Text] [Related]
25. Inflammatory markers in patients with coronary artery disease with and without inflammatory rheumatic disease.
Breland UM; Hollan I; Saatvedt K; Almdahl SM; Damås JK; Yndestad A; Mikkelsen K; Førre OT; Aukrust P; Ueland T
Rheumatology (Oxford); 2010 Jun; 49(6):1118-27. PubMed ID: 20231178
[TBL] [Abstract][Full Text] [Related]
26. Venous Thromboembolism in the Inflammatory Rheumatic Diseases.
Misra DP; Ahmed S; Goyal M; Sharma A; Agarwal V
Rheum Dis Clin North Am; 2023 Feb; 49(1):97-127. PubMed ID: 36424029
[TBL] [Abstract][Full Text] [Related]
27. Invasive techniques--from diagnosis to treatment.
Maisch B; Pankuweit S; Karatolios K; Ristić AD
Rheumatology (Oxford); 2006 Oct; 45 Suppl 4():iv32-8. PubMed ID: 16980721
[TBL] [Abstract][Full Text] [Related]
28. Cardiorheumatology: cardiac involvement in systemic rheumatic disease.
Prasad M; Hermann J; Gabriel SE; Weyand CM; Mulvagh S; Mankad R; Oh JK; Matteson EL; Lerman A
Nat Rev Cardiol; 2015 Mar; 12(3):168-76. PubMed ID: 25533796
[TBL] [Abstract][Full Text] [Related]
29. Can cardiovascular magnetic resonance prompt early cardiovascular/rheumatic treatment in autoimmune rheumatic diseases? Current practice and future perspectives.
Mavrogeni SI; Sfikakis PP; Dimitroulas T; Koutsogeorgopoulou L; Katsifis G; Markousis-Mavrogenis G; Kolovou G; Kitas GD
Rheumatol Int; 2018 Jun; 38(6):949-958. PubMed ID: 29516170
[TBL] [Abstract][Full Text] [Related]
30. Cardiovascular co-morbidity in rheumatic diseases.
Turesson C; Jacobsson LT; Matteson EL
Vasc Health Risk Manag; 2008; 4(3):605-14. PubMed ID: 18827910
[TBL] [Abstract][Full Text] [Related]
31. Comparative assessment of vascular function in autoimmune rheumatic diseases: considerations of prevention and treatment.
Soltész P; Kerekes G; Dér H; Szücs G; Szántó S; Kiss E; Bodolay E; Zeher M; Timár O; Szodoray P; Szegedi G; Szekanecz Z
Autoimmun Rev; 2011 May; 10(7):416-25. PubMed ID: 21281743
[TBL] [Abstract][Full Text] [Related]
32. Cardiovascular risk in the rheumatic disease patient undergoing orthopedic surgery.
Goodman SM; Mackenzie CR
Curr Rheumatol Rep; 2013 Sep; 15(9):354. PubMed ID: 23888363
[TBL] [Abstract][Full Text] [Related]
33. Inflammasomes and rheumatic diseases: evolving concepts.
Sidiropoulos PI; Goulielmos G; Voloudakis GK; Petraki E; Boumpas DT
Ann Rheum Dis; 2008 Oct; 67(10):1382-9. PubMed ID: 17921182
[TBL] [Abstract][Full Text] [Related]
34. The rationale for comparative studies of accelerated atherosclerosis in rheumatic diseases.
Gasparyan AY; Stavropoulos-Kalinoglou A; Mikhailidis DP; Toms TE; Douglas KM; Kitas GD
Curr Vasc Pharmacol; 2010 Jul; 8(4):437-49. PubMed ID: 19758114
[TBL] [Abstract][Full Text] [Related]
35. Increased levels of serum pentraxin 3, a novel cardiovascular biomarker, in patients with inflammatory rheumatic disease.
Hollan I; Bottazzi B; Cuccovillo I; Førre ØT; Mikkelsen K; Saatvedt K; Almdahl SM; Mantovani A; Meroni PL;
Arthritis Care Res (Hoboken); 2010 Mar; 62(3):378-85. PubMed ID: 20391484
[TBL] [Abstract][Full Text] [Related]
36. [How T lymphocytes coordinate rheumatic inflammation].
Chang HD; Radbruch A; Kallinich T; Mashreghi MF; Hegazy AN; Kruglov A; Nedospasov S; Baumgrass R
Z Rheumatol; 2022 Oct; 81(8):635-641. PubMed ID: 35380250
[TBL] [Abstract][Full Text] [Related]
37. [The heart in rheumatic diseases].
Specker C
Internist (Berl); 2007 Mar; 48(3):284-9. PubMed ID: 17226010
[TBL] [Abstract][Full Text] [Related]
38. Accelerated atherosclerosis in inflammatory rheumatic diseases.
Haskard DO
Scand J Rheumatol; 2004; 33(5):281-92. PubMed ID: 15513675
[TBL] [Abstract][Full Text] [Related]
39. Cardiovascular involvement in systemic rheumatic diseases: An integrated view for the treating physicians.
Lee KS; Kronbichler A; Eisenhut M; Lee KH; Shin JI
Autoimmun Rev; 2018 Mar; 17(3):201-214. PubMed ID: 29353099
[TBL] [Abstract][Full Text] [Related]
40. Cytokines in rheumatic diseases.
Miller LC
Biotherapy; 1994; 8(2):99-111. PubMed ID: 8924358
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
